258 related articles for article (PubMed ID: 34058468)
1. APOE gene variants in primary dyslipidemia.
Khalil YA; Rabès JP; Boileau C; Varret M
Atherosclerosis; 2021 Jul; 328():11-22. PubMed ID: 34058468
[TBL] [Abstract][Full Text] [Related]
2.
Abou Khalil Y; Marmontel O; Ferrières J; Paillard F; Yelnik C; Carreau V; Charrière S; Bruckert E; Gallo A; Giral P; Philippi A; Bluteau O; Boileau C; Abifadel M; Di-Filippo M; Carrié A; Rabès JP; Varret M
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628605
[TBL] [Abstract][Full Text] [Related]
3. Additive Effect of
Marmontel O; Abou-Khalil Y; Bluteau O; Cariou B; Carreau V; Charrière S; Divry E; Gallo A; Moulin P; Paillard F; Peretti N; Rabès JP; Varret M; Carrié A; Di Filippo M
Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):e270-e278. PubMed ID: 37128917
[TBL] [Abstract][Full Text] [Related]
4. APOE p.Leu167del mutation in familial hypercholesterolemia.
Awan Z; Choi HY; Stitziel N; Ruel I; Bamimore MA; Husa R; Gagnon MH; Wang RH; Peloso GM; Hegele RA; Seidah NG; Kathiresan S; Genest J
Atherosclerosis; 2013 Dec; 231(2):218-22. PubMed ID: 24267230
[TBL] [Abstract][Full Text] [Related]
5. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.
Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M
Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841
[TBL] [Abstract][Full Text] [Related]
6. Contribution of
Bea AM; Larrea-Sebal A; Marco-Benedi V; Uribe KB; Galicia-Garcia U; Lamiquiz-Moneo I; Laclaustra M; Moreno-Franco B; Fernandez-Corredoira P; Olmos S; Civeira F; Martin C; Cenarro A
Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):1066-1077. PubMed ID: 37051929
[TBL] [Abstract][Full Text] [Related]
7. Update on the molecular biology of dyslipidemias.
Ramasamy I
Clin Chim Acta; 2016 Feb; 454():143-85. PubMed ID: 26546829
[TBL] [Abstract][Full Text] [Related]
8. Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.
Wintjens R; Bozon D; Belabbas K; MBou F; Girardet JP; Tounian P; Jolly M; Boccara F; Cohen A; Karsenty A; Dubern B; Carel JC; Azar-Kolakez A; Feillet F; Labarthe F; Gorsky AM; Horovitz A; Tamarindi C; Kieffer P; Lienhardt A; Lascols O; Di Filippo M; Dufernez F
J Lipid Res; 2016 Mar; 57(3):482-91. PubMed ID: 26802169
[TBL] [Abstract][Full Text] [Related]
9. The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes.
Cenarro A; Etxebarria A; de Castro-Orós I; Stef M; Bea AM; Palacios L; Mateo-Gallego R; Benito-Vicente A; Ostolaza H; Tejedor T; Martín C; Civeira F
J Clin Endocrinol Metab; 2016 May; 101(5):2113-21. PubMed ID: 27014949
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Marais AD
Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
[TBL] [Abstract][Full Text] [Related]
12. Impact of rare variants in autosomal dominant hypercholesterolemia causing genes.
Calandra S; Tarugi P; Bertolini S
Curr Opin Lipidol; 2017 Jun; 28(3):267-272. PubMed ID: 28323660
[TBL] [Abstract][Full Text] [Related]
13. [Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
Češka R; Štulc T; Votavová L; Schwarzová L; Vaclová M; Freiberger T
Vnitr Lek; 2016; 62(11):887-894. PubMed ID: 28128575
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
[TBL] [Abstract][Full Text] [Related]
15. APOE and familial hypercholesterolemia.
Civeira F; Martín C; Cenarro A
Curr Opin Lipidol; 2024 Aug; 35(4):195-199. PubMed ID: 38640077
[TBL] [Abstract][Full Text] [Related]
16. Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation.
Marduel M; Ouguerram K; Serre V; Bonnefont-Rousselot D; Marques-Pinheiro A; Erik Berge K; Devillers M; Luc G; Lecerf JM; Tosolini L; Erlich D; Peloso GM; Stitziel N; Nitchké P; Jaïs JP; ; Abifadel M; Kathiresan S; Leren TP; Rabès JP; Boileau C; Varret M
Hum Mutat; 2013 Jan; 34(1):83-7. PubMed ID: 22949395
[TBL] [Abstract][Full Text] [Related]
17. Cosegregation of serum cholesterol with cholesterol intestinal absorption markers in families with primary hypercholesterolemia without mutations in LDLR, APOB, PCSK9 and APOE genes.
Baila-Rueda L; Pérez-Ruiz MR; Jarauta E; Tejedor MT; Mateo-Gallego R; Lamiquiz-Moneo I; de Castro-Orós I; Cenarro A; Civeira F
Atherosclerosis; 2016 Mar; 246():202-7. PubMed ID: 26802983
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.
Smelt AH; de Beer F
Semin Vasc Med; 2004 Aug; 4(3):249-57. PubMed ID: 15630634
[TBL] [Abstract][Full Text] [Related]
19. Genetic Analysis of Japanese Children Clinically Diagnosed with Familial Hypercholesterolemia.
Nagahara K; Nishibukuro T; Ogiwara Y; Ikegawa K; Tada H; Yamagishi M; Kawashiri MA; Ochi A; Toyoda J; Nakano Y; Adachi M; Mizuno K; Hasegawa Y; Dobashi K
J Atheroscler Thromb; 2022 May; 29(5):667-677. PubMed ID: 34011801
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
